![]() |
市場調查報告書
商品編碼
1316257
全球 DHA 市場 - 2023-2030 年Global DHA Market - 2023-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
全球DHA 市場規模在2022 年達到7.802 億美元,預計到2030 年將達到11.095 億美元,預計在2023-2030 年期間將以4.5% 的複合年成長率成長。推動DHA 市場成長的主要原因是其對健康的益處。在一項研究中,食用DHA 可使類風濕性關節炎症狀減輕28%。由於炎症與心臟病有關,減少炎症也可降低冠心病的風險。
由於注重健康的人越來越多,二十二碳六烯酸在各行各業的應用也越來越廣泛。二十二碳六烯酸在全球的消費量越來越大,促進了市場的擴大。由於二十二碳六烯酸在預防和治療疾病方面具有多種優勢,因此其使用和生產都在不斷擴大。
二十二碳六烯酸市場作為一個整體,受益於日常飲食中保健品用量的增加。全球二十二碳六烯酸市場成長的主要障礙是缺乏合適的替代品。此外,口臭、異味、頭痛等負面副作用也阻礙了人們使用含二十二碳六烯酸的產品。
DHA 具有許多健康益處。眾所周知,大腦中的DHA 含量會隨著年齡的成長而降低,這與散發性阿滋海默症的發病有關。心血管疾病是西方國家的主要殺手。根據世界衛生組織2021 年的報告,心血管疾病(CVDs)估計每年奪走1,790 萬人的生命,是全球死亡的主要原因。
冠心病、腦血管病、風濕性心臟病和其他疾病都屬於被稱為CVDs 的心臟和血管疾病。每五例心血管疾病死亡病例中,就有四例以上死於心臟病發作和中風,其中三分之一的死亡病例發生在70 歲之前。由於心臟病的流行,消費者開始選擇補充DHA,從而推動了DHA 市場的成長。
孕婦或哺乳期婦女每天至少應攝入200 毫克DHA。根據最近的一項研究,目前的建議可能過低。根據Stoutjesdijk 等人的研究,婦女在懷孕三個月期間每天應攝入535+215 毫克DHA+EPA ,在哺乳期的第一個月每天應攝入715+285 毫克DHA+EPA ,以確保新生兒獲得最佳濃度的LCPUFAs。
重要的是,只需每週食用必要的10 盎司(2-3 餐)魚即可獲得這些LCPUFAs。然而,並沒有多少美國人食用這麼多魚。美國人每周平均只吃4 盎司魚,還不到建議量的一半。
DHA 具有抗炎特性,這也是它對炎症和心臟健康有益的原因之一。不過,研究人員指出,過量的DHA 偶爾會以某種方式改變免疫功能,導致對細菌或病毒感染的免疫反應無效。人體對抗細菌等微生物感染的能力可能會受到因攝入過量DHA 而導致免疫系統功能失調的影響。
COVID-19 分析包括COVID 前情景、COVID 情景和COVID 後情景,以及定價動態(包括大流行期間和之後的定價變化,並與COVID 前情景進行比較)、供求光譜(由於貿易限制、封鎖和後續問題而導致的供需變化)、政府計劃(政府機構為振興市場、部門或行業而採取的計劃)和製造商戰略計劃(此處將涵蓋製造商為緩解COVID 問題而採取的措施)。
Global DHA Market reached US$ 780.2 million in 2022 and is expected to reach US$ 1,109.5 million by 2030 and is expected to grow with a CAGR of 4.5% during the forecast period 2023-2030. The primary driver for DHA market growth is owing to its health benefits. In a study, eating DHA reduced rheumatoid arthritis symptoms by 28%. Since inflammation and heart disease are related, reducing inflammation may also reduce your risk of coronary events.
Docosahexaenoic acid is being used more frequently across a variety of industries as a result of the rise in the number of health-conscious people. Docosahexaenoic acid is increasingly being consumed globally, which is fostering market expansion. Because of the multiple advantages it offers in terms of disease prevention and treatment, docosahexaenoic acid use and production have expanded.
The market for docosahexaenoic acid as a whole benefit from the rising usage of health supplements in daily diet. The primary barrier to growth in the worldwide docosahexaenoic acid market is the lack of suitable replacements. Furthermore, negative side effects like foul breath, bad taste, headaches, and others discourage people from using docosahexaenoic acid-based goods.
DHA is associated with plenty of health benefits. DHA levels in the brain are known to decrease with age and are linked to the start of sporadic Alzheimer's disease. Cardiovascular disease is the main killer in Western countries. Cardiovascular diseases (CVDs), which claim an estimated 17.9 million lives annually, are the leading cause of mortality worldwide, according to the WHO report 2021.
Coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other illnesses are among the category of heart and blood vessel disorders known as CVDs. Heart attacks and strokes account for more than four out of every five CVD deaths, and one-third of these deaths happen before the age of 70. Due to the prevalence of heart diseases, consumers are opting for DHA supplements, which is driving the DHA market growth.
Women who are expecting or nursing should take at least 200 mg of DHA daily. The current suggestion may be too low, according to a recent study. According to Stoutjesdijk et al., women should eat 535 + 215mg DHA+EPA per day during the third trimester and 715 + 285mg DHA+EPA per day during the first month of breastfeeding in order to ensure that the newborn has access to the optimum concentrations of LCPUFAs.
Importantly, obtaining these amounts of LCPUFAs can be accomplished simply by eating the necessary 10 oz (2-3 meals) of fish each week. However, not many Americans consume as much fish. The weekly average for Americans is only 4 oz, which is less than half the advised quantity.6 Additionally, the most popular types are low in LCPUFAs.
DHA has anti-inflammatory characteristics, which is one of the reasons it may be good for inflammation and heart health. However, the researchers noted that excessive DHA can occasionally change immune function in ways that may cause an ineffective immune response to a bacterial or viral infection. The body's capacity to combat microbial infections like bacteria can be impacted by an immune system that isn't functioning properly due to excessive DHA ingestion.
The COVID-19 Analysis includes Pre-COVID Scenario, COVID Scenario and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it with pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).
The global DHA market is segmented based on source, application, end-user, and region.
The global DHA market has been segmented by application into animal feed, pharmaceuticals, functional food and beverages, cosmetics, and others. The pharmaceuticals segment held the largest DHA market share of 42.8% in 2022 in the DHA market analysis report. Dietary supplements, infant formula, and maternal nutrition are the wide applications of DHA in the pharmaceutical industry.
DHA is essential for the growth of nerve and ocular structures. By reducing blood thickness, inflammation, and lipid levels in circulation, DHA may help minimize the chance of developing vision health, cognitive development, and circulatory disease. DHA is frequently used by people to treat high blood fat or cholesterol levels. Additionally, it is used to improve memory and cognitive abilities, assist newborn and child development, treat some eye diseases, and treat a variety of other ailments.
The global DHA market is segmented into five parts of the world based on geography: North America, South America, Europe, Asia Pacific, the Middle East, and Africa. The Asia-Pacific DHA market held the largest market share of 32.6% in 2022 in the DHA market analysis. The demand in the region is anticipated to increase as consumers become more aware of the advantages of consuming DHA supplements.
Customers in this region choose to consume DHA-rich fish in their diets over items made from algae. As a result, food producers do not believe it is worthwhile to increase production costs by substituting pricey algal omega-3 fatty acids components for ones derived from fish. Due to rising knowledge of the critical role that DHA plays in brain development and other essential processes, there has also been an increase in the demand among youngsters to meet their essential nutritional needs.
The major global players in the market include: BASF SE, Clover Corporation, Croda Inc., Nordic Naturals, Omega Protein Corporation, DSM N.V., Cargill, Incorporated., Copeinica, Epax, and Givaudan.
The DHA market was significantly impacted by COVID-19. During the epidemic, consumer purchasing habits altered. This resulted from a rise in consumer demand in wholesome, nutritious meals. Because consuming these goods improves physical and mental health, DHA-containing products are among the top choices of customers. For instance, one of the major competitors in this market, Archer Daniels Midland Company, predicted a rise of 76% in the first quarter of fiscal 2021.
The market is expanding as a result of factors like growing consumer knowledge of the health advantages of DHA. As more people live longer, the industry is likewise becoming more significant and a component of consumers' regular diets.
The global DHA market report would provide approximately 61 tables, 61 figures, and 190 Pages.
LIST NOT EXHAUSTIVE